CRU 2025: A closeup of diagnostic approaches and examination tips for DED and OSD

News
Video

Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.

During their CRU 2025 presentation "The ABCs of DED and OSD," Cecelia Koetting, OD, FAAO, DipABO, and Madeline Yung, MD, focused on ocular surface disease and dry eye diagnosis, emphasizing a comprehensive approach to patient evaluation. In an exclusive interview with Optometry Times, Koetting shared the following:

Diagnostic approach

  • Thoroughly examine the entire eye system, including eyelids, lid closure, conjunctiva, and tear drainage system

Diagnostic techniques

  • Use vital dyes, particularly fluorescein
  • Analyze staining patterns carefully
  • Look beyond traditional dyes like lissamine green or rose bengal
  • Observe staining location and extent

Staining pattern insights

  • Different staining patterns can reveal underlying issues: - Inferior staining might indicate sleeping with eyes open - metamucosa could result from preserved eye drops

Examination recommendations

  • Conduct a detailed slit lamp examination
  • Pay attention to patient conversation and visual cues
  • Don't rush through the initial examination

Diagnostic significance

  • Staining patterns help identify: - Specific dry eye causes - Potential treatment directions - Underlying eye health issues

Holistic patient assessment

  • Look beyond technical measurements
  • Engage in meaningful conversation
  • Observe patient's overall eye health and symptoms

Koetting emphasizes the importance of a meticulous, patient-centered approach to diagnosing ocular surface disease, highlighting that careful observation and comprehensive examination are crucial for accurate diagnosis and effective treatment.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, ponders what she would like to see develop as both a researcher and a clinician in the dry eye space.
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, discussed research that utilized IQVIA longitudinal prescription claims data from September through November 2023, coinciding with Miebo's FDA approval in September.
Steven Greenstein, MD, one of the cochairs of the Collaborative Care Symposium gave some insight into the upcoming conference and what attendees can expect.
© 2025 MJH Life Sciences

All rights reserved.